iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by Northwestern Mutual Wealth Management Co.

Northwestern Mutual Wealth Management Co. decreased its position in iShares Biotechnology ETF (NASDAQ:IBB) by 8.0% during the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 37,632 shares of the financial services provider’s stock after selling 3,292 shares during the period. Northwestern Mutual Wealth Management Co.’s holdings in iShares Biotechnology ETF were worth $5,166,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the company. BNP Paribas Financial Markets grew its holdings in iShares Biotechnology ETF by 25.7% in the first quarter. BNP Paribas Financial Markets now owns 2,055,373 shares of the financial services provider’s stock valued at $282,038,000 after purchasing an additional 420,053 shares during the last quarter. Main Management ETF Advisors LLC boosted its stake in shares of iShares Biotechnology ETF by 2.6% during the second quarter. Main Management ETF Advisors LLC now owns 578,835 shares of the financial services provider’s stock valued at $79,451,000 after acquiring an additional 14,535 shares during the last quarter. Global Assets Advisory LLC acquired a new stake in shares of iShares Biotechnology ETF during the first quarter valued at $66,059,000. Raymond James Financial Services Advisors Inc. boosted its stake in shares of iShares Biotechnology ETF by 24.6% during the second quarter. Raymond James Financial Services Advisors Inc. now owns 217,047 shares of the financial services provider’s stock valued at $29,792,000 after acquiring an additional 42,822 shares during the last quarter. Finally, Commonwealth Equity Services LLC boosted its stake in shares of iShares Biotechnology ETF by 5.3% during the first quarter. Commonwealth Equity Services LLC now owns 198,709 shares of the financial services provider’s stock valued at $27,267,000 after acquiring an additional 10,033 shares during the last quarter. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Up 0.0 %

IBB opened at $144.80 on Thursday. iShares Biotechnology ETF has a 52 week low of $111.83 and a 52 week high of $150.57. The business’s fifty day simple moving average is $145.68 and its 200 day simple moving average is $138.97.

iShares Biotechnology ETF Dividend Announcement

The business also recently disclosed a dividend, which was paid on Monday, September 30th. Investors of record on Wednesday, September 25th were paid a dividend of $0.2005 per share. The ex-dividend date was Wednesday, September 25th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.